Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Aronson

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Transfusion|October 1, 1990
The development of the technology and capacity for the production of factor VIII for the treatment of hemophilia AD L Aronson
Circulation|August 1, 1983
Overview of thrombolysisD L Aronson
American Journal of Hematology|January 1, 1988
Cause of death in hemophilia A patients in the United States from 1968 to 1979D L Aronson
Progress in Clinical and Biological Research|January 1, 1984
There is no correlation between vitamin K dependent coagulant content and clinical effectiveness of activated and standard factor IX complex concentratesD L Aronson
Lancet (London, England)|October 29, 1983
Pneumonia deaths in haemophiliacsD L Aronson
Journal of Clinical Apheresis|January 1, 1993
Infection of hemophiliacs with HIVD L Aronson
Seminars in Thrombosis and Hemostasis|January 1, 1979
Factor IX complexD L Aronson
Progress in Clinical and Biological Research|January 1, 1981
Conjectures on factor VIII bypassing activityD L Aronson
The New England Journal of Medicine|April 11, 1974
Letter: Inhibition of thrombotic effect of factor IXD L Aronson
Progress in Clinical and Biological Research|January 1, 1990
Strategies for the validation of viral inactivation in biologic productsD L Aronson
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Transfusion|October 1, 1990
The development of the technology and capacity for the production of factor VIII for the treatment of hemophilia AD L Aronson
Circulation|August 1, 1983
Overview of thrombolysisD L Aronson
American Journal of Hematology|January 1, 1988
Cause of death in hemophilia A patients in the United States from 1968 to 1979D L Aronson
Progress in Clinical and Biological Research|January 1, 1984
There is no correlation between vitamin K dependent coagulant content and clinical effectiveness of activated and standard factor IX complex concentratesD L Aronson
Lancet (London, England)|October 29, 1983
Pneumonia deaths in haemophiliacsD L Aronson
Journal of Clinical Apheresis|January 1, 1993
Infection of hemophiliacs with HIVD L Aronson
Seminars in Thrombosis and Hemostasis|January 1, 1979
Factor IX complexD L Aronson
Progress in Clinical and Biological Research|January 1, 1981
Conjectures on factor VIII bypassing activityD L Aronson
The New England Journal of Medicine|April 11, 1974
Letter: Inhibition of thrombotic effect of factor IXD L Aronson
Progress in Clinical and Biological Research|January 1, 1990
Strategies for the validation of viral inactivation in biologic productsD L Aronson
Pageof 7